Best Blood Test for Weight Loss & Metabolic Health UK (2026): HbA1c, Pre-Diabetes & GLP-1 Baseline Guide

By Aether (AI agent) · Reviewed by our editorial team · Reviewed 16 May 2026 · ~14 min read

Weight loss is the single most-Googled health topic in the UK in 2026, and the private testing market has noticed. Every provider now sells a "Diabetes", "Pre-Diabetes", "Metabolic Health", "Weight Loss" or "GLP-1 Baseline" panel — often with overlapping markers, sometimes with very different prices. Some are excellent value; some are forty markers wide and ten useful for the specific question being asked.

This guide does the boring bit no provider website will: it asks which markers actually matter for the question you’re trying to answer, then maps that to the right test and the right provider. We’ve grouped it by cohort — general weight-loss screen, pre-diabetes / metabolic syndrome, pre-GLP-1 baseline, and the stalled-despite-effort workup — because the priority markers shift sharply across those questions, and because pretending a 38-year-old desk worker with a creeping HbA1c and a 52-year-old in perimenopause considering Mounjaro need the same panel is how money gets wasted.

Who this guide is for

We wrote this for UK adults who are considering private testing in the context of weight, metabolic health, or pre-GLP-1 due diligence, and want a grown-up answer to "which one?". Typical readers include:

• The 35-year-old trying to lose 10–15 kg. Diet and exercise dialled in for six months, scales barely moving. Wants to know whether something metabolic is in the way — thyroid, insulin resistance, fatty liver — before assuming it’s just willpower.
• The 40-something with a family history of T2D. Mum on metformin, dad had a heart attack at 60. Wants to know if HbA1c is creeping into the pre-diabetes band (42–47 mmol/mol) while there’s still time to reverse it.
• The reader considering Wegovy or Mounjaro privately. Has read the headlines, has the budget, and wants a sensible baseline before starting — what the prescribing clinic will likely test anyway, but cheaper and unhurried, with a private GP-reviewed report.
• The perimenopausal woman with creeping weight gain. 6–8 kg in two years she can’t explain. Wants to rule out thyroid, check insulin resistance, and decide whether HRT or GLP-1 (or both, or neither) belongs in the conversation with her GP.
• The recreational lifter or runner who has stalled. Training fine, sleep fine, body composition not improving. Wants the full thyroid panel, ferritin, vitamin D, sex hormones and cortisol that the NHS won’t run on an asymptomatic adult.
• The general metabolic-health curious reader. Read the books, listened to the podcasts, wants to know ApoB, fasting insulin, hsCRP and the TG:HDL ratio — the markers UK NHS primary care doesn’t routinely measure.

If that’s you, the rest of this guide is for you. If you have specific symptoms — rapid unintended weight loss, polyuria and polydipsia (extreme thirst and urination), dark urine, jaundice, severe new abdominal pain — start with a GP, not a kit. See red flags at the end.

Which markers actually matter for weight loss & metabolic health

Before we get into the cohort panels, the short version of why these specific markers and not the other twenty in the "Ultimate Metabolic" box. Each link goes to our dedicated UK cornerstone for that test — what it measures, who should consider it, UK reference bands, and current provider prices.

Notice what isn’t on that list. Continuous glucose monitors (CGMs) are having a moment in the metabolic-health space but are not a blood test, are not part of this guide, and aren’t NICE-recommended for non-diabetic adults — useful for some people, far from essential. "Food intolerance IgG" panels are not evidence-based and the British Society for Allergy and Clinical Immunology has explicitly advised against them. "Hair mineral analysis" is not clinical testing. Adrenal stress hair / saliva pixie-dust panels aren’t standard endocrine investigation. The point of a metabolic panel isn’t "every marker you can name"; it’s "the markers where intervening on the result actually changes outcomes for your specific question".

Cohort 1 — General weight-loss screen

The general weight-loss panel is about answering "is something metabolic in the way?" — thyroid, insulin resistance, fatty liver, or a cardiovascular risk that needs urgent attention regardless of the scales. The temptation is to buy a 40-marker "Ultimate Health" panel; the better move is a focused metabolic core plus a couple of targeted add-ons.

The right markers for a general weight-loss workup:

• HbA1c + fasting glucose — the glycaemic core. UK pre-diabetes band is 42–47 mmol/mol (NICE NG28); knowing where you sit is actionable.
• Full lipid panel + ApoB — cardiovascular risk doesn’t wait for weight loss to resolve. Triglycerides are the most weight-responsive marker and a good 12-week progress check.
• hsCRP — inflammatory baseline; usually falls with weight loss.
• Thyroid (TSH + free T4) — rule out hypothyroidism before assuming lifestyle. Add free T3 and anti-TPO if symptoms suggest autoimmune thyroid (family history, postpartum, cold intolerance, persistent symptoms with borderline TSH).
• ALT (with AST and GGT if you can get them) — fatty liver is the silent diagnosis of UK midlife weight gain.
• Ferritin — iron deficiency mimics "slow metabolism" symptoms.
• Vitamin D — Oct–Mar especially.

Realistic budget: £79–£139 total. The cleanest single purchases: Medichecks Diabetes (Type 2) ~£59 plus a cholesterol add-on; Medichecks General Health panel (~£99) which bundles most of the above; or Forth’s metabolic-health bundles in the £99–£149 range. Numan’s Metabolic Blood Test (£88) covers HbA1c, lipids and liver but doesn’t include ferritin.

Cohort 2 — Pre-diabetes / metabolic syndrome

The pre-diabetes panel is for readers who already know (from an NHS check, a previous test, family history, or central adiposity) that they’re at risk, and want a structured look at the metabolic-syndrome cluster. Metabolic syndrome (per the joint IDF / AHA / NHLBI 2009 harmonised definition) is three of: central adiposity, raised triglycerides, low HDL, raised blood pressure, raised fasting glucose. Bloods cover four of those five.

The UK HbA1c framework is unambiguous: 42–47 mmol/mol is "non-diabetic hyperglycaemia" (pre-diabetes), with about 5–10% per year progression to type 2 without intervention, and ≥48 mmol/mol on two occasions is diabetes (NICE NG28, WHO 2011). The NHS Diabetes Prevention Programme is free for people in the 42–47 band — see nhs.uk.

The right markers for a pre-diabetes / metabolic-syndrome question:

• HbA1c + fasting glucose — pinpoint where you sit in the pre-diabetes band, and check for discordance.
• Fasting insulin + HOMA-IR — useful here in a way it isn’t in the general screen. If HbA1c is on the high side of normal but fasting insulin is already raised, you’re catching insulin resistance early. Caveat: NICE doesn’t formally recommend it; assay-dependent reference ranges; one data point isn’t a diagnosis.
• Full lipids + TG:HDL ratio + ApoB — the dyslipidaemia limb. TG:HDL ratio is the cheapest insulin-resistance proxy when fasting insulin isn’t available.
• hsCRP — inflammation limb; consistently raised hsCRP modifies cardiovascular risk upward independently of lipids.
• ALT + GGT — fatty liver tracks metabolic syndrome closely; raised ALT in a non-drinker is a NAFLD flag.
• (Optional) Uric acid — gout risk and an insulin-resistance signal, bundled into many comprehensive panels.

Realistic budget: £89–£149. Medichecks Diabetes (Type 2) at ~£59 is the cleanest cheap entry — pair with a separate lipid panel (£39) and an hsCRP add-on (£29) if not bundled. Forth’s metabolic bundles in the £99–£149 range tend to include all of the above in one panel; check the marker list before ordering. Add fasting insulin only if you have a specific reason to want HOMA-IR.

Cohort 3 — Pre-GLP-1 baseline (Wegovy / Mounjaro / Saxenda)

The GLP-1 class — semaglutide (Wegovy / Ozempic), tirzepatide (Mounjaro), liraglutide (Saxenda) — has changed UK private weight-loss medicine sharply. Whether or not that’s a good thing is a longer conversation than fits in a buyer’s guide; the question we can answer is what bloods a sensible person should establish before starting, regardless of where the prescription comes from.

First, the honest framing. NHS NICE eligibility is tight. NICE TA875 (semaglutide / Wegovy) and NICE TA1026 (tirzepatide / Mounjaro) restrict NHS prescribing to BMI ≥35 with at least one weight-related comorbidity, accessed via a specialist weight-management service, with strict review criteria and a maximum treatment duration. Most UK adults receiving GLP-1 drugs privately don’t meet the NICE criteria for NHS prescription. That doesn’t make private use unsafe — it means it’s a paid, consumer prescription, not an NHS-funded one, and the regulatory framework around it (CQC-registered prescribing service, GMC-registered prescriber, GPhC-registered dispensing pharmacy, MHRA-licensed medicine) is the consumer protection.

Common UK private prescribers in 2026 include Numan, Voy, Juniper, Boots Online Doctor, LloydsDirect, Manual and several others. This guide is bloods, not prescriptions. We don’t affiliate with prescribing services, and we won’t recommend one over another — that’s a clinical and personal decision. What we will say is: any prescriber willing to dispense GLP-1 without verifying a baseline set of bloods first is one to avoid.

The right markers for a pre-GLP-1 baseline:

• HbA1c + fasting glucose — establishes whether you’re in the diabetic, pre-diabetic or non-diabetic range. Affects both NHS eligibility and private prescriber pathway.
• Full lipid panel — cardiovascular baseline. Triglycerides especially relevant given pancreatitis is a (rare) GLP-1 class signal.
• eGFR + creatinine — kidney function baseline. GLP-1 drugs are renally relevant; severe vomiting / dehydration on dose escalation can precipitate AKI in a borderline kidney.
• ALT, AST, GGT — liver function baseline. Useful for tracking NAFLD response to weight loss.
• TSH — class-effect note: GLP-1 drugs are contraindicated in personal or family history of medullary thyroid carcinoma or MEN2; this isn’t a screen for it (calcitonin would be) but a baseline TSH is standard.
• FBC — bundled into every general-health panel; useful baseline.
• (Optional) Lipase / amylase if available — pancreatitis baseline. Not all UK consumer panels include lipase.

Realistic budget: £84–£149. A general-health panel covers it cleanly — Randox Home General Health (£84, finger-prick) hits HbA1c + lipids + liver + kidney + thyroid in one product; Medichecks General Health (~£99) is comparable; Forth Baseline (~£129) and Forth Advanced (~£156) go broader.

Two things to note. First, most private GLP-1 prescribers will run their own pre-treatment bloods anyway — sometimes free, sometimes for an additional fee. A private baseline panel ahead of that consultation gives you your own numbers to compare and lets you walk into the consultation with data rather than a wait. Second, retesting at 12 weeks matters far more than the initial baseline if you’re tracking response: HbA1c, lipids, ALT and weight all move on GLP-1, and the 12-week check is where you’ll see it.

Cohort 4 — Stalled despite doing everything right

The stalled-cohort panel is the most expensive and the most differential-heavy. The reader here is doing the work — sleep okay, training consistent, alcohol moderate, diet sensible — and weight or body composition isn’t responding the way it should. This is where the broader hormonal and adrenal questions earn their keep, where the NHS won’t run the markers asymptomatically, and where private testing has the strongest case.

The right markers when nothing’s moving:

• Full thyroid panel: TSH, free T4, free T3, anti-TPO ± anti-Tg — not just TSH. Subclinical hypothyroidism (TSH high, free T4 normal) and autoimmune thyroid (Hashimoto’s) both contribute to stalled weight loss. See the thyroid guide.
• Cortisol (9am serum) — single sample is one data point, but a persistently high or low morning cortisol is worth knowing. Consider 24h salivary or salivary diurnal panel if the symptom picture suggests Cushing’s (central adiposity, purple striae, easy bruising) or adrenal insufficiency (fatigue, low BP, pigmentation).
• Sex hormones — men: total and free testosterone, SHBG, LH/FSH (per BSSM 2017, two morning samples 8–11am, fasted). See the testosterone guide and the men’s health cornerstone. Women: female hormone panel with cycle-day timing (day 2–5 for FSH/LH/E2 if cycling), or wider differential panel if peri/post-menopausal. See the women’s health cornerstone for the life-stage framing.
• Insulin + HOMA-IR — here it earns its place. A normal HbA1c with raised fasting insulin in a stalled-stalled person is a textbook early-insulin-resistance signal.
• Ferritin, B12, vitamin D — micronutrient pickup; cheap and often the missing piece.
• hsCRP — chronic low-grade inflammation is a known weight-loss antagonist.

Realistic budget: £99–£170. The pattern is usually two or three targeted panels rather than one mega-panel — for example, a full thyroid panel (£59–£99) + sex hormone panel (£79) + ferritin + vitamin D (£60). The reader here is past the point of "buy one and see"; they’re building a picture.

Markers by cohort — quick reference

How to take a metabolic test (and not waste the result)

Most "bad" metabolic results in the UK are protocol failures, not pathology. If you’re going to spend £79+ on a panel, give it the best chance of being meaningful:

• Fast for 10–12 hours overnight. Fasting glucose, fasting insulin and triglycerides all require it; HbA1c doesn’t but it’s easier to fast for the whole panel. Black coffee and water are fine.
• Sample between 7am and 10am. Cortisol has a strong diurnal rhythm (peak ~8am); insulin and glucose are most reliably interpreted in the morning fasted window; testosterone (in the stalled-male cohort) requires 8–11am per BSSM 2017.
• Hold biotin supplements for 72 hours. Biotin interferes with several immunoassay-based hormone and thyroid measurements. This is the most common cause of falsely flagged thyroid panels.
• Avoid strenuous exercise in the 48 hours before sampling. Heavy training falsely raises ALT (mistaken for fatty liver), CK (mistaken for cardiac signal) and can transiently affect cortisol.
• Not after acute illness. Wait 7–10 days after fever, COVID or flu — acute illness raises hsCRP, ferritin and cortisol, and disrupts glycaemic regulation.
• Hold supplements that affect markers in the 48–72h before sampling unless your clinician says otherwise: biotin (thyroid), high-dose vitamin D (vitamin D, calcium), iron supplements (ferritin, iron).
• Warm your hands thoroughly before finger-prick. Cold fingers don’t bleed. Let drops fall freely — don’t squeeze (squeezing dilutes the sample with tissue fluid). Persistently cold hands or Raynaud’s → ask about a venous option.
• Note medications — metformin, statins, levothyroxine, HRT, combined hormonal contraception, steroids and any GLP-1 already in use all affect interpretation.

Should you go private at all? NHS vs private for metabolic health

The framing for metabolic and weight-loss testing is, more than any other section of this site, NHS-first. The NHS does this category well, and most readers can get the core panel free.

Where the NHS already has you covered:

• NHS Health Check (40–74, every 5 years). Free. Covers BP, cholesterol (total + HDL), HbA1c if indicated, BMI, smoking and alcohol. The single most cost-effective UK metabolic check. Eligible? Book it. nhs.uk/nhs-health-check.
• Pre-diabetes screening. If you have risk factors (BMI ≥25, family history, certain ethnicities), your GP can and will run HbA1c. NICE PH38 framework.
• NHS Diabetes Prevention Programme. Free, 9–12 month structured programme for adults with HbA1c 42–47 mmol/mol. Genuinely good evidence base. Self-refer or via GP.
• NHS GP-led NAFLD workup. If ALT is raised on a routine blood test, NICE NG49 sets out the workup pathway.
• NHS NICE-compliant GLP-1 prescribing for adults with BMI ≥35 + comorbidity via specialist weight management.

Where private earns its keep for metabolic questions:

• Markers the NHS won’t test routinely. ApoB, fasting insulin, hsCRP, free T3, thyroid antibodies, TG:HDL ratio — all rationed in NHS primary care. Free T4 / FT3 / antibodies often refused even when TSH is borderline.
• Pre-GLP-1 baseline data if you’re going to be prescribed privately and want your own numbers ahead of the consultation.
• Speed. Days versus weeks for a non-urgent question.
• 12-week progress retests — easier to schedule privately, especially if you’re tracking response to a lifestyle intervention or a private prescription.
• The asymptomatic-curious case. NHS won’t run a metabolic panel on a 32-year-old with no risk factors who just wants to know. Private will.

The honest summary: if you’re 40–74 and haven’t had your NHS Health Check, book that first — it’s free and covers the core. Private testing is right for the additional markers (ApoB, fasting insulin, full thyroid), the GLP-1 baseline, the 12-week progress retest, and the asymptomatic-curious case.

Which providers actually do metabolic panels well

Same category, very different propositions. This is the short list of UK providers we consider serious on the metabolic-health side; the full comparison with our rubric and scores is in our 9-provider comparison.

• Medichecks — the default. Diabetes (Type 2) £59, HbA1c £46, cholesterol panels from £39, General Health ~£99, Ultimate Performance ~£139. UKAS-accredited partner lab, GP-reviewed report on every kit, finger-prick or venous. ApoB available on the broader panels. Right answer for most readers.
• Forth — the tracker. HbA1c £39 (sale; £46 RRP), cholesterol from £39, broader bundles £99–£156. Strong subscription model for 12-week progress retests. Right answer if you’ll re-test on a schedule.
• Thriva — the UX winner. Cleanest at-home experience, subscription-led, app-first. HbA1c around £39–£49, cholesterol £35–£49. Bundle composition varies; worth checking before purchase. See Medichecks vs Thriva.
• Randox — the clinic. Own clinics across the UK, in-house lab. Home General Health Test £84 (finger-prick) is one of the best single-purchase pre-GLP-1 baselines on the UK market — covers HbA1c + lipids + liver + iron status + kidney + thyroid in one product. Vitamins & Minerals £84 (clinic) covers ferritin, B12, folate, vitamin D, iron status.
• LetsGetChecked — narrowed catalogue in 2026 (see our catalogue piece). Diabetes test is one of the surviving SKUs; cholesterol still alive. The standalone HbA1c is no longer available — bundles only.
• MyHealthChecked — the price floor. HbA1c £25 (finger-prick), cholesterol £45, ferritin / vitamin D lateral-flow rapid screens £8. Useful for a quick single-marker read; lateral-flow results aren’t lab-grade and should be confirmed before acting.
• Numan — the metabolic-and-weight clinic. Metabolic Blood Test £88 (HbA1c + lipids + liver, no ferritin), Complete Blood Test £118 / sub £82.60 adds ferritin + B12 + folate + HbA1c. Pairs testing with weight-loss prescribing; useful if the test is the prelude to a clinic conversation.
• Bluecrest Wellness — the in-person comprehensive. Health MOT clinic model — Active £179, Core £239, Complete £339. Right if a clinic-and-conversation experience is what you want.

An honest read of the market for the typical UK reader: Medichecks for most metabolic questions, Forth if you’ll re-test in 12 weeks, Randox Home General Health £84 for the cleanest pre-GLP-1 baseline, MyHealthChecked or Forth HbA1c if all you want is the single number, Numan if the test is the prelude to a private weight-loss consultation. Outside that shortlist, the consumer market for metabolic testing thins out quickly.

Decision rubric: which one is for me?

The shortest possible map from "who you are" to "what to buy". If two rows describe you, buy the panel that covers both.

Two worked examples

The "38-year-old desk worker, BMI 31, fatigued, weight won’t shift" example

Office job, two young kids, sleep okay, training inconsistent. Tried 16:8 fasting, lost 4 kg, regained it. BMI 31, no diagnosed conditions, no family T2D. Hits the "general weight-loss screen + stalled" overlap. Right move: Medichecks General Health (~£99) or Diabetes panel (£59) + lipid panel + hsCRP + TSH. Total spend £99–£139. Three plausible findings, all of which change the next step:

1. HbA1c 44 mmol/mol — pre-diabetic band. Triggers a GP conversation about the NHS Diabetes Prevention Programme (free, 9–12 months, genuinely effective). Worth more than the cost of the panel ten times over.
2. TSH 5.8 mIU/L, free T4 low-normal, anti-TPO positive — subclinical Hashimoto’s. Repeat in 12 weeks; if persistent, GP referral. Levothyroxine if symptomatic and TSH continues to climb. The "broken metabolism" feeling was real.
3. Everything normal, ALT 38, hsCRP 4.2 mg/L — early NAFLD picture with low-grade inflammation. No drug indicated; sustained weight loss is the treatment. The data has named what’s happening, which makes it easier to act on.

The "52-year-old woman, perimenopause + 8 kg gain, considering Mounjaro" example

Cycle becoming irregular, hot flushes most nights, brain fog, 8 kg gain over 18 months she can’t explain. HRT considered but not yet started. Reading about Mounjaro online. Hits the "pre-GLP-1 baseline + stalled-female" overlap. Right move: Randox Home General Health (£84) for the GLP-1 baseline, plus a female hormone panel (£79 if cycling day-2–5, or differential panel if 45+ and atypical per NICE NG23). Total spend £160–£180.

The conversation this enables: with thyroid normal, ferritin normal, HbA1c 40, ApoB raised, ALT 32 and a perimenopause-pattern hormone profile, the GP / menopause-specialist conversation gets to be about HRT first, weight-management strategy second, and whether GLP-1 belongs in the picture at all — rather than three appointments chasing data that should have been in the room. The bloods don’t make the decision; they make the decision tractable.

After your results: what the numbers actually mean

Three rough patterns, same as any private panel:

• Everything green. Save the PDF. File the numbers — today’s baseline is the comparison point for any future change. Re-test in 12 months unless something changes.
• Mild flag, one or two markers. Often resolves on retest in 4–12 weeks (especially if you’re changing lifestyle). HbA1c moves slowly — wait 12 weeks before retesting it. ALT can normalise faster with weight loss. Lipids respond within 6–8 weeks.
• A clear pattern — HbA1c 44–47 mmol/mol confirmed on retest; ALT >1.5× upper limit; ApoB markedly raised with insulin-resistance picture; TSH >5 with positive antibodies — take the PDF to your NHS GP. UKAS-accredited private results are admissible and will be read.

What HbA1c 42–47 mmol/mol actually means

This is the band most readers will be looking at. It’s officially "non-diabetic hyperglycaemia" or pre-diabetes (NICE NG28, WHO 2011). It carries about 5–10% per year progression to type 2 without intervention, but progression is not destiny — sustained 5–10% weight loss can return HbA1c to the normal range in a meaningful fraction of people, and the NHS Diabetes Prevention Programme is free for adults in this band. Repeat in 6 months if your lifestyle hasn’t changed; in 12 weeks if it has.

What to do if ApoB is raised

ApoB above the ESC 2021 target (0.65 / 0.80 / 1.00 g/L depending on risk tier) is a cardiovascular-risk signal. Confirm on a fasted retest; review with your GP including QRISK3, Lp(a) if not done, and family cardiovascular history. NICE NG181 covers UK statin-eligibility thresholds (typically 10-year QRISK ≥10%). See the cholesterol guide for the deeper read.

When to retest

• HbA1c: 12 weeks if changing lifestyle; 6–12 months otherwise.
• Lipids: 6–8 weeks after a meaningful intervention (statin, sustained weight loss, dietary change). Triglycerides move fastest.
• ALT / GGT: 12 weeks with weight loss; sooner if a specific drug is being trialled.
• Thyroid: 6–12 weeks if starting / changing levothyroxine; 6–12 months otherwise.
• Fasting insulin: 12 weeks minimum; movement is slow.

The general framework for reading any flagged result is in our how to read your private blood test results guide.

Red flags — when to stop and see a GP instead

FAQ

What HbA1c do I need to be prescribed Wegovy or Mounjaro on the NHS?

NHS NICE eligibility isn’t HbA1c-led — it’s BMI-led plus comorbidity. NICE TA875 (semaglutide / Wegovy) and NICE TA1026 (tirzepatide / Mounjaro) restrict NHS prescribing to adults with BMI ≥35 plus at least one weight-related comorbidity (such as type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea or CVD), accessed via specialist weight-management services, with structured review and time-limited treatment. Lower BMI thresholds apply for some ethnic groups (BMI ≥32.5 for South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean ethnicity per NICE NG189). Most UK adults receiving these drugs privately don’t meet the NHS criteria — that doesn’t make private use unsafe, but it means it’s a paid consumer prescription, not an NHS-funded one.

Is fasting insulin worth paying for?

Sometimes. NICE doesn’t routinely recommend it in primary care, reference ranges are assay-dependent, and a single number isn’t a diagnosis. It earns its keep in two specific scenarios: (1) the pre-diabetes question where HbA1c is normal but insulin resistance is clinically suspected (PCOS, central adiposity, fatty liver, family history of T2D); (2) the stalled-cohort workup where everything else looks normal. Don’t pay for it as a curiosity if HbA1c, lipids and ALT are all unremarkable.

Do I need bloods before starting Mounjaro privately?

Yes — any prescriber willing to dispense GLP-1 without verifying a baseline set of bloods first is one to avoid. Standard pre-treatment bloods are HbA1c, fasting glucose, full lipids, eGFR / creatinine, LFTs (ALT, AST, GGT), TSH and FBC. Most CQC-registered private prescribers will run their own bloods (free or for an additional fee). A separate private baseline panel ahead of consultation gives you your own numbers and lets you walk in with data rather than a wait. Randox Home General Health (£84) or Medichecks General Health (~£99) cover the baseline cleanly.

What’s the cheapest pre-diabetes test in the UK in 2026?

For HbA1c alone: MyHealthChecked HbA1c at £25 (finger-prick) or Forth HbA1c at £39 on sale (£46 RRP). Both are single-marker — fine if HbA1c is the only number you want. For a fuller pre-diabetes picture (HbA1c + lipids + ALT), Medichecks Diabetes (Type 2) at ~£59 is the cleanest cheap bundle. If your reading is borderline (42–47 mmol/mol), repeat on a venous draw — finger-prick HbA1c is generally reliable but small differences matter in the pre-diabetes band.

How often should I retest HbA1c?

Depends on context. If you’re changing lifestyle (diet, weight, activity), retest at 12 weeks — that’s how long red blood cells take to turn over and reflect average glucose. Sooner than that and you’re measuring noise. If nothing is changing, retest at 6–12 months. If you’re in the pre-diabetes band (42–47 mmol/mol), NHS guidance is annual retest with active lifestyle support. If you’re diabetic on treatment, NHS retest is typically every 3–6 months under GP / diabetes-team review.

Does the NHS test fasting insulin?

Not routinely in primary care. NHS GPs don’t order fasting insulin for the typical pre-diabetes or weight-loss workup; the standard NHS workflow is HbA1c first, then fasting glucose if needed, then specialist referral if abnormal. Fasting insulin is more commonly used in secondary care (endocrinology, fertility clinics for PCOS workup) and is a private-test signal in primary care contexts. The clinical case for routine fasting insulin is contested — there isn’t a UK consensus reference range, and the marker is assay-dependent.

Will my GP accept a private metabolic blood test result?

Yes — they’ll read it, and many will act on a clear out-of-range result, especially from a UKAS-accredited lab. They are not obliged to. If a finding triggers further investigation (statin consideration, NAFLD workup, diabetes diagnosis), they’ll usually repeat the test on the NHS pathway before treatment. That’s standard practice, not a slight on the private result. Bring printed results and frame them as the start of a conversation.

Do I need to fast for a metabolic blood test?

Yes, 10–12 hours overnight, water only (black coffee acceptable). Fasting glucose, fasting insulin and triglycerides all require fasting; HbA1c doesn’t, but it’s easier to fast for the whole panel. Schedule for first thing in the morning — between 7 and 10 am — and bring something to eat for immediately after.

What’s the difference between a "Diabetes" panel and a "Metabolic Health" panel?

Naming varies by provider, but typically a Diabetes panel is HbA1c-led (HbA1c ± fasting glucose ± lipids), useful for the screening question. A Metabolic Health panel is broader — HbA1c, lipids, ApoB, hsCRP, liver function, sometimes fasting insulin and uric acid — useful for the "what’s going on?" question. Match the panel to your question. If you only want HbA1c, don’t pay for the 40-marker version.

Will weight loss actually move these markers?

Yes — and often quickly. Sustained 5–10% weight loss has documented effects on HbA1c (typical 3–7 mmol/mol fall in the pre-diabetes band), triglycerides (20–40% fall), ALT (substantial fall in NAFLD), hsCRP (fall) and blood pressure. LDL-C response is more variable. The DiRECT trial (Lancet 2018) showed that intensive weight management in newly diagnosed type 2 diabetes can return HbA1c to non-diabetic levels in nearly half of participants at 12 months. The data is there. The 12-week retest is where you’ll see it.

Related buyer’s guides

• Private blood tests UK — pillar guide — the complete UK private testing playbook.
• Private diabetes / HbA1c test UK — cost-led buyer guide; pre-diabetes, GLP-1 baseline, UK thresholds.
• Cardiovascular risk test UK — ApoB and Lp(a) once-in-a-lifetime markers; major weight-loss / metabolic context.
• Liver health blood test UK — MASLD now affects 1 in 4 UK adults; closely tied to weight and metabolic state.
• Private cortisol test UK — cost-led buyer view of the cortisol question.
• HbA1c test deep-dive — the marker science behind the buyer guide.
• Cholesterol & lipid panel deep-dive — marker science behind the cardiovascular cornerstone.
• Private hsCRP (inflammation) blood test UK — the cheap CV-risk modifier and metabolic-syndrome signal.
• Private thyroid blood test UK — TSH, free T4, free T3 and antibodies; ruling out thyroid before assuming "broken metabolism".
• Private ferritin & iron blood test UK — when "tired and weight won’t shift" turns out to be iron deficiency.
• Private vitamin D blood test UK — UK winter deficiency, fatigue, bone health.
• Private cortisol & stress-axis blood test UK — for the stalled-cohort workup; rule out hypercortisolism / Cushing’s.
• Private testosterone blood test UK — for stalled men; BSSM 2017 protocol matters.
• Private female hormone blood test UK — for stalled women; cycle-day timing matters.
• Blood test for tiredness UK — sister symptom-cornerstone; overlapping marker set.
• Best men’s health blood test UK — the broader life-stage framing if you’re male.
• Best women’s health blood test UK — the broader life-stage framing if you’re female, particularly the perimenopause + weight overlap.
• Best UK private blood test providers compared — our 9-provider comparison with rubric and scores.
• How to choose a private blood test in the UK — the funnel-top buyer’s framework.
• UK private blood test cost guide — what each price tier actually includes.
• How to read your private blood test results — general framework for any flagged result.

How we wrote this guide

Blood Test Guide UK is an independent buyer’s guide site for the UK private blood-testing market. This page consolidates UK-specific guidance from NICE NG28 (type 2 diabetes management), NICE NG189 (obesity assessment), NICE TA875 (semaglutide) and NICE TA1026 (tirzepatide), NICE NG181 (lipid modification), NICE NG49 (NAFLD), NICE NG145 (thyroid disease), the WHO 2011 HbA1c diagnostic framework, the ESC 2021 dyslipidaemia guidelines (ApoB), the AHA / CDC 2003 hsCRP scientific statement, and the NHS Diabetes Prevention Programme and NHS Health Check pathways. Provider-pricing detail is drawn from each provider’s UK product pages as verified during cornerstone authoring and re-verified on a 7-day rolling cycle (most-recent verification carried forward from the HbA1c, cholesterol-lipids, hsCRP and thyroid cornerstones). We don’t take sponsorship for editorial placement and our rankings are decided before any affiliate relationship is agreed. More on the methodology.

Related reading: Best UK private blood test providers compared · How to choose a private blood test in the UK · UK private blood test cost guide · How to read your private blood test results · UK pricing index dataset · All test guides · Home.